Clas Malmeström - Concepedia

Author

Clas Malmeström

Also Known As

C Malmestrom, C Malmeström, C. Malmeström, C. Malmeström, Clas Malmestrom, Clas Malmeström, Clas Malmeström, Malmeström C, Malmeström, C.

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

University of Gothenburg Sahlgrenska University Hospital University College London National Hospital for Neurology and Neurosurgery Karolinska Institutet

About

Clas Malmeström is an author at University of Gothenburg specializing in multiple sclerosis, medicine, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	806
2	Immunology	9	9	592
3	Clinical Immunology	2	2	122
4	Allergy	1	1	37
5	Cell Biology	1	1	77

Clas Malmeström

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein Lenka Novakova, Henrik Zetterberg, Peter Sundström, Neurology	2017	409
Rituximab in multiple sclerosis Jonatan Salzer, Rasmus Svenningsson, Peter Alping, Neurology	2016	340
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab Martin Gunnarsson, Clas Malmeström, Markus Axelsson, Annals of Neurology	2010	337
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS Clas Malmeström, Sara Haghighi, Lars Rosengren, Neurology	2003	315
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study Jens Kühle, Giulio Disanto, Ruth Dobson, Multiple Sclerosis Journal	2015	290
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients Peter Alping, Thomas Frisell, Lenka Novakova, Annals of Neurology	2016	224
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis Markus Axelsson, Clas Malmeström, Staffan Nilsson, Journal of Neurology Neurological DisorderMedicinePotential BiomarkerPathologyBiomarkers	2010	186
Inflammation-related plasma and CSF biomarkers for multiple sclerosis Jesse Huang, Mohsen Khademi, Lars Fugger, Proceedings of the National Academy of Sciences	2020	178
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing‐remitting multiple sclerosis Lenka Novakova, Markus Axelsson, Mohsen Khademi, Journal of Neurochemistry	2016	141
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis Markus Axelsson, Clas Malmeström, Martin Gunnarsson, Multiple Sclerosis Journal	2013	126

Page 1